Convergent Mechanisms of Extreme Longevity: From Comparative Genomics to Translational Interventions

Abstract

Long-lived species across phylogenetically distant lineages exhibit convergent molecular adaptations that collectively preserve cellular homeostasis and suppress
age-related deterioration. Genome-wide analyses spanning bivalves, parrots, bowhead whales, and bats reveal robust signatures of positive selection in DNA repair and tumor suppressor genes, including elevated dN/dS ratios and amino acid substitutions in conserved functional domains of *BRCA1*, *ATM*, *PARP1*, *BRCA2*, *RAD51*, and *TP53*. PARP1 emerges as the most convergently selected longevity gene across phylogenetically distant taxa (bivalves, parrots, mammals), exhibiting adaptive changes in both DNA repair and NAD+ metabolism functions, with positive correlation between PARP1 activity and mammalian longevity.
Epigenetic mechanisms, including convergent hypomethylation at promoter CpG sites and experimental evidence that DNA methylation regulators causally influence aging, demonstrate that long-lived species maintain or reset protective methylation patterns. Telomere maintenance strategies diverge along body size
thresholds, with species exceeding 5–10 kg convergently repressing telomerase and maintaining shorter telomeres as anti-cancer mechanisms, while small long-lived
species (bats, naked mole rats) maintain constitutive telomerase with hyperactivated Rb/p53 pathways (≥3-fold increase, Rš¿0.8 correlation with lifespan). Pro-
teostasis networks—exemplified by HSP-6 overexpression reducing amyloid-β proteotoxicity in *C. elegans*—bolster cellular resilience. Genomic stability is further
preserved through piRNA-mediated surveillance, KRAB-ZFP/TRIM28 silencing, and DNA methylation that suppress transposable element mobilization, whose activation threatens genome integrity and triggers innate immune responses. Long-lived species, centenarians, and females exhibit convergent immune adaptations
through coordinated downregulation of NLRP3 inflammasome, TLR/NF-κB, and cGAS/STING pathways alongside preserved NK cell and naive T-cell function,
demonstrating inflammaging is a tractable rather than inevitable phenotype. Non-coding regulatory elements orchestrate circadian-metabolic integration and stem
cell dynamics, with comparative studies demonstrating that approximately 60% of orthologous longevity genes maintain domain-level functional conservation. Adi-
pose triglyceride lipase (ATGL/PNPLA2) represents the most immediately druggable longevity target with validated crystal structure (PDB: 5UIQ), established
lipase enzyme class druggability, and functional conservation from C. elegans bmm to mammalian orthologs in fatty acid oxidation pathways. Tissue-specific
CRISPR delivery efficiency creates a ’delivery-before-discovery paradox’: prime editing achieves 42-46% efficiency in cortex/liver but only 11% in cardiac tissue, while PFV-LNPs improve retinal delivery by 50%, revealing that therapeutic bottleneck is delivery not target identification. These convergent mechanisms—spanning
epigenetic regulation, mitochondrial-nuclear signaling, DNA repair, telomere maintenance, protein quality control, and anti-inflammatory pathways—suggest that
longevity arises from integrated networks balancing stress response, proteostasis, genome stability, and immune modulation rather than single pathways.

This demonstration version does not separately label hypothesis-based reasoning from sourced reasoning; full hypothesis tracing is available for researchers who
require it.